Category: Product recalls

Recalls of over-the-counter medications, though infrequent, are a normal part of consumer safety and can happen for a variety of reasons. For those who rely on this popular antihistamine, the question, 'Has Claritin been recalled?' has come up periodically over the years, prompting concern among consumers. While there have been limited recalls involving specific lots of Claritin and its generic versions, these are typically not due to a widespread health risk but rather issues with manufacturing or packaging. This article provides a comprehensive overview of past Claritin and generic loratadine recalls, explaining the details and the safety measures in place to protect consumers.

As of September 2024, over 3 million tubes of REFRESH P.M. and REFRESH Lacri-Lube lubricant eye ointments have been recalled by their manufacturer, Abbvie (Allergan), due to a potential issue with the tube seals. This was a Class II recall, meaning the product use may cause temporary or medically reversible adverse health consequences. Understanding which REFRESH eye drops are being recalled is critical for consumers to ensure their safety and protect their eye health.

In 2023, a series of urgent safety alerts were issued, with the FDA reporting infections linked to contaminated eye drops that resulted in hospitalizations, vision loss, and even death. These alerts led to widespread recalls, leaving many consumers wondering what three eye drops are recalled and what actions they need to take to ensure their safety.

In September 2024, a Class II recall was issued for several lots of Refresh PM lubricant eye ointment by its manufacturer, AbbVie (Allergan), addressing consumer concerns like 'Is there a recall on Refresh PM lubricant eye ointment?'. The recall was prompted by sterility concerns due to compromised tube seals, affecting over 3 million tubes across several countries.

In early 2023, the Centers for Disease Control and Prevention (CDC) linked an outbreak of a rare, drug-resistant bacteria to two types of artificial tears, leading to severe health outcomes, including blindness. For those asking which two eye drops are recalled in this major event, the products were EzriCare Artificial Tears and Delsam Pharma Artificial Tears. While this specific incident involved two key products, numerous other eye drop recalls have been issued by the FDA in recent years due to various contamination and manufacturing issues, underscoring the importance of staying informed about product safety.

Since its introduction, various manufacturers of tamsulosin, including those producing generic versions, have issued recalls for the drug due to manufacturing defects and contamination concerns. The most common issues leading to these recalls include the failure of capsules to dissolve properly and the discovery of carcinogenic impurities like nitrosamines.

In February 2025, NeilMed Pharmaceuticals voluntarily recalled over 89,000 bottles of its NasoGel Spray due to a potential “microbial failure,” causing concern among consumers asking: which nasal spray was recalled?. Product recalls are a critical safety measure used by the U.S. Food and Drug Administration (FDA) to protect public health from potentially dangerous or defective medications and medical devices. This article details the specific products involved in recent nasal spray recalls and the reasons behind them.

In early 2025, a significant number of nasal spray products were subject to recalls due to potential microbial contamination and other quality issues. This has raised urgent questions for consumers, including **what nasal spray is being recalled?**, and highlights the critical importance of staying informed about medication safety alerts from the FDA and manufacturers.